wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39007500-1E478DD1-E57B-44DC-8B07-CDBD18668B10
Q39007500-1E478DD1-E57B-44DC-8B07-CDBD18668B10
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39007500-1E478DD1-E57B-44DC-8B07-CDBD18668B10
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer.
P2860
Q39007500-1E478DD1-E57B-44DC-8B07-CDBD18668B10
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39007500-1E478DD1-E57B-44DC-8B07-CDBD18668B10
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eb5782971ea3ec2d8647b16e3205c3355bdb6c4a
P2860
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer.